950 — Lee's Pharmaceutical Holdings Balance Sheet
0.000.00%
- HK$783.15m
- HK$690.71m
- HK$1.40bn
- 94
- 91
- 89
- 100
Annual balance sheet for Lee's Pharmaceutical Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 415 | 278 | 189 | 171 | 217 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 386 | 354 | 213 | 185 | 280 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,239 | 963 | 652 | 657 | 785 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 725 | 688 | 541 | 443 | 401 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 3,253 | 3,637 | 2,782 | 2,891 | 2,618 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 944 | 923 | 650 | 649 | 771 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,103 | 1,172 | 858 | 852 | 966 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 2,150 | 2,465 | 1,924 | 2,039 | 1,652 |
Total Liabilities & Shareholders' Equity | 3,253 | 3,637 | 2,782 | 2,891 | 2,618 |
Total Common Shares Outstanding |